Also trades as: IPOT.CN (CNQ) · $vol 0M
ISCNF OTC
Isracann Biosciences Inc.
1W: +900.0%
1M: +900.0%
3M: +0.0%
YTD: +900.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$42K
-1.0% ▼
Operating Income
-$2M
+49.9% ▲
Net Income
-$5M
+81.3% ▲
EPS (Diluted)
$-0.03
+82.3% ▲
EBITDA
-$2M
+49.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $1M | $0 | $0 | $0 | $0 |
| YoY Growth | +264.9% | -100.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $45K | $45K | $41K | $42K |
| Gross Profit | $1M | -$45K | -$45K | -$41K | -$42K |
| Gross Margin | 100.0% | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7M | $6M | $12M | $5M | $3M |
| Operating Expenses | $1M | $6M | $12M | $5M | $2M |
| Operating Income | -$6M | -$6M | -$11M | -$5M | -$2M |
| Operating Margin | -535.5% | — | — | — | — |
| Interest Expense | $120K | $0 | $0 | $139K | $14K |
| Income Before Tax | -$7M | -$6M | -$24M | -$25M | -$5M |
| Tax Expense | $0 | $0 | -$68K | $31K | $0 |
| Net Income | -$7M | -$10M | -$24M | -$25M | -$5M |
| Net Margin | -636.9% | — | — | — | — |
| EPS (Diluted) | $-0.33 | $-0.75 | $-0.26 | $-0.18 | $-0.03 |
| EBITDA | -$7M | -$5M | -$11M | -$5M | -$2M |
| Shares Outstanding | 23M | 13M | 93M | 138M | 148M |